Glycine/lysine acetylsalicylate inhalation (Ventaleon)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGlycine/lysine acetylsalicylate inhalation (Ventaleon)
Drug Alias NameLASAGActi-INSP-001VR-736
ClassificationSmall molecules
Mechanisms of ActionVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVectura Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVentaleonVectura Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A